BRIEF published on 07/01/2026 at 15:49, 4 months 6 days ago Vivendi : Mise à jour sur les droits de vote et le capital social Droits De Vote Franchissement De Seuil Capital Social Vivendi NYSE Euronext
BRIEF published on 07/01/2026 at 15:49, 4 months 6 days ago Vivendi: Update on voting rights and share capital Share Capital Voting Rights Threshold Crossing Vivendi NYSE Euronext
BRIEF published on 07/01/2026 at 15:34, 4 months 6 days ago Edison Releases Report on SDCL Efficiency Income Trust for FY26 Dividends Debt Reduction Portfolio Valuation SDCL Efficiency Income Trust FY26 Results
BRIEF published on 07/01/2026 at 15:34, 4 months 6 days ago Edison publie un rapport sur le fonds de revenu d'efficacité SDCL pour l'exercice 2026 Dividendes Réduction De La Dette Évaluation De Portefeuille SDCL Efficiency Income Trust Résultats De L'exercice 2026
BRIEF published on 07/01/2026 at 15:32, 4 months 6 days ago Pentixapharm Initiates Capital Expansion for PANDA Phase 3 and U.S. Growth Capital Increase Rights Issue U.S. Expansion Pentixapharm PANDA Phase 3
BRIEF published on 07/01/2026 at 15:32, 4 months 6 days ago Pentixapharm lance une levée de fonds pour financer la phase 3 de son essai clinique PANDA et sa croissance aux États-Unis. Augmentation De Capital Pentixapharm Émission De Droits Expansion Américaine PANDA Phase 3
BRIEF published on 07/01/2026 at 15:17, 4 months 6 days ago Vanguard Discloses Position in Tate & Lyle plc Form 8.3 Takeover Code Vanguard Group Shareholding Disclosure Tate & Lyle
BRIEF published on 07/01/2026 at 15:17, 4 months 6 days ago Vanguard révèle sa participation dans Tate & Lyle plc Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Déclaration Relative À L'actionnariat Tate & Lyle
BRIEF published on 07/01/2026 at 15:17, 4 months 6 days ago Abivax reprend la cotation de ses actions sur Euronext Paris Euronext Paris Biotechnologie Actions Abivax Suspension
BRIEF published on 07/01/2026 at 15:17, 4 months 6 days ago Abivax resumes trading of its shares on Euronext Paris Euronext Paris Biotechnology Actions Abivax Suspension
Published on 11/06/2026 at 22:15, 1 day 15 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 1 hour ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 1 hour ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/08/2026 at 12:10, 1 hour 39 minutes ago GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap
Published on 11/08/2026 at 10:15, 3 hours 34 minutes ago 2026 China International Intelligent Communication Forum Held in Wuxi
Published on 11/07/2026 at 13:35, 1 day ago Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 1 day 17 hours ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 1 day 17 hours ago L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:06, 1 day 18 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 1 day 18 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 1 day 18 hours ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 1 day 18 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
